Open AccessPB2111: SUBGROUP ANALYSIS IN RE‐MIND2, AN OBSERVATIONAL, RETROSPECTIVE COHORT STUDY OF TAFASITAMAB + LENALIDOMIDE VERSUS SYSTEMIC THERAPIES IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA
Author(s) -
Nowakowski G. S.,
Yoon D. H.,
Joffe E.,
Zinzani P. L.,
Sabatelli L.,
Waltl E. E.,
Alvero C. G.,
Hess G.,
Riedell P.,
Kim K.,
Brixner D.,
Salles G.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000851276.20930.ad
Subject(s) - medicine , rituximab , lenalidomide , diffuse large b cell lymphoma , oncology , propensity score matching , bendamustine , cohort , retrospective cohort study , surgery , lymphoma , multiple myeloma